Pharmafile - Manufacturing and Production News
Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult...
Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design and manufacture of its silicon...
MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters of cancer cases at an early...
The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium.
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022. Taking place in Leipzig, Germany...
Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of...
The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT).
AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor Xa inhibitors...
UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to severe plaque psoriasis...
Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment for their condition. ZTALMY® (...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
